Validation of the Hospital Anxiety and Depression Scale in Patients with Decompensated Cirrhosis

Chengbo Zeng,John Donlan,Teresa Indriolo,Lucinda Li,Enya Zhu,Joyce C Zhou,Malia E Armstrong,Kedie Pintro,Nora Horick,Raymond T Chung,Areej EI-Jawahri,Maria O Edelen,Nneka N Ufere

DOI: https://doi.org/10.1101/2024.07.05.24310010

2024-07-07

Abstract:Background: The Hospital Anxiety and Depression Scale (HADS) demonstrates strong psychometric properties in many populations of patients with serious illness. However, its psychometric performance among patients with decompensated cirrhosis (DC) has not been examined. We investigated the reliability, validity, and responsiveness of the HADS for patients with DC. Methods: This observational study utilized data from patients with DC at enrollment and week 6 follow-up. Two hundred eighteen outpatients with DC were recruited from a liver transplant center, with 145 completing week 6 assessment. We evaluated psychological distress using HADS and Patient Health Questionnaire 9 (PHQ-9). Patients' health-related quality of life (HRQOL) was assessed using the Short-Form Liver Disease Quality of Life questionnaire. We examined reliability, floor/ceiling effects, structural validity, and known-groups validity for anxiety (HADS-Anxiety) and depression (HADS-Depression) subscales. We assessed the convergent validity with the PHQ-9. We predicted the change in HRQOL using the change in depression and anxiety. We also evaluated the internal responsiveness to changes in HRQOL for both HADS-Anxiety and HADS-Depression from baseline to week 6. Results: The HADS-Anxiety and HADS-Depression subscales showed strong internal consistency (Cronbach's alpha>0.8), adequate floor/ceiling effects (<15%), and excellent convergent validity with PHQ-9 (r>0.7). Both domains significantly predicted the changes in HRQOL longitudinally. Both HADS-Anxiety (1.8 [95% confidence interval [CI]: 0.5, 3.2]) and HADS-Depression (2.2 [95%CI: 1, 3.4]) showed responsiveness in patients with decreased HRQOL. Conclusions: The HADS is a reliable, valid, responsive tool for assessing anxiety and depression among patients with DC.

Gastroenterology

What problem does this paper attempt to address?

The aim of this paper is to address the issue of evaluating the psychometric properties of the Hospital Anxiety and Depression Scale (HADS) in patients with Decompensated Cirrhosis (DC). Specifically, the study aims to validate the reliability, validity, and sensitivity to changes in Health-Related Quality of Life (HRQOL) of HADS in both cross-sectional and longitudinal aspects. The study hypothesizes that the anxiety and depression subscales of HADS can:

1. Demonstrate high reliability, minimal floor and ceiling effects, and robust structural validity;
2. Show good convergent validity with the Patient Health Questionnaire (PHQ-9) and strong predictive validity for changes in HRQOL;
3. Be responsive to longitudinal changes in HRQOL.

Through these validations, the study aims to demonstrate that HADS is an effective tool for assessing anxiety and depression in DC patients and to support its application in clinical practice and research.